NutriBand (NTRB) Interest Coverage Ratio (2019 - 2026)
NutriBand's (NTRB) quarterly Interest Coverage Ratio came in at 191.4 in Q1 2026, up 87.13% year-on-year from 102.28 in Q1 2025, and up 72.63% quarter-over-quarter from 699.41 in Q4 2025.
NutriBand (NTRB) Interest Coverage Ratio (2019 - 2026) Analysis & Trends
NutriBand has disclosed Interest Coverage Ratio across 8 years of filings, most recently posting 191.4 for Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 191.4, up 87.13% year-over-year; the trailing twelve-month figure through Jan 2026 was 369.11 (up 23.17% YoY), and the FY2026 annual result was 369.11, up 23.17% from the prior year.
- Interest Coverage Ratio came in at 191.4 for Q1 2026 at NutriBand, up from 699.41 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 15.32 in Q1 2023 to a low of 1486.7 in Q1 2025.
- The 5-year median for Interest Coverage Ratio is 240.39 (2025), against an average of 355.04.
- Across the five-year window, Interest Coverage Ratio sank 4190.82% in 2022 and surged 101.28% in 2023, its largest moves.
- NutriBand's Interest Coverage Ratio stood at 270.18 in 2022, then jumped by 84.13% to 42.87 in 2023, then sank by 725.61% to 353.97 in 2024, then plunged by 97.59% to 699.41 in 2025, then jumped by 72.63% to 191.4 in 2026.
- The last three Interest Coverage Ratio figures came in at 191.4 (Q1 2026), 699.41 (Q4 2025), and 347.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 3.58 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -258.33 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 11.50 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 11.79 |
| 10 | NutriBand | 41.91 Mn | 37.33 Mn | 88,941.00 | -191.40 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -191.40 |
| Oct 31, 2025 | -699.41 |
| Jul 31, 2025 | -347.00 |
| Apr 30, 2025 | -240.39 |
| Jan 31, 2025 | -1,486.70 |
| Oct 31, 2024 | -353.97 |
| Jul 31, 2024 | -280.88 |
| Apr 30, 2024 | -219.25 |
| Jan 31, 2024 | -56.27 |
| Oct 31, 2023 | -42.87 |
| Jul 31, 2023 | -89.25 |
| Apr 30, 2023 | -321.50 |
| Jan 31, 2023 | 15.32 |
| Oct 31, 2022 | -270.18 |
| Jul 31, 2022 | -233.52 |
| Apr 30, 2022 | -21.13 |
| Jan 31, 2022 | -1,197.30 |
| Oct 31, 2021 | -46.09 |
| Jul 31, 2021 | -11.76 |
| Apr 30, 2021 | -7.68 |